Oral

This session will help the public health community understand the authority granted in 2009 to the Food and Drug Administration (FDA) to regulate tobacco, limitations on that authority, and the ways in which federal, state, and local tobacco control efforts can complement each other. FDA established the Center for Tobacco Products in August, 2009 to implement this new regulatory authority to reduce tobacco-related illness and death nationwide. Since its inception, the Center has recognized the importance of strengthening the existing science base to support the regulation of tobacco products. To counteract this authority, cigarette manufacturers and others are moving aggressively to develop, test, and market many non-cigarette commercial tobacco products, also called “other tobacco products,” hoping to capitalize on declining cigarette use and to exploit loopholes in regulations that were written with cigarettes in mind.

Session Objectives: Assess the impact of the 2009 Tobacco Control Act. Evaluate options to regulate non-cigarette tobacco products. Describe new rresearch efforts in tobacco control.

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)